SYDNEY--(BUSINESS WIRE)--Uscom (ASX: UCM) Uscom Limited today signed a deed to acquire all assets of Pulsecor Limited. Pulsecor Limited is a New Zealand company which has developed novel non-invasive ...
A phase I study to define the optimal low dose of NGR-hTNF, a novel vascular targeting agent (VTA), in combination with cisplatin in patients (pts) with solid tumors ...
Uscom (ASX:UCM) chairman Prof Rob Phillips says the China-focused respiratory device maker’s “disappointing” decision to sell its assets at a fire-sale price resulted from a potent mix of factors ...
Uscom chairman Professor Rob Phillips says the device maker’s misfortune was shaped by a series of exogenous events, including US tariffs. Uscom (ASX:UCM) chairman Prof Rob Phillips says the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results